Loading clinical trials...
Loading clinical trials...
Mesenchymal stem cells (MSCs) have been reported to be effective to prevent alveolar growth arrest in experimental bronchopulmonary dysplasia (BPD). The aim is to treat the extremely premature infant ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
China Medical University Hospital
NCT05446272 · Extubation Failure, Bronchopulmonary Dysplasia, and more
NCT06915441 · Bronchopulmonary Dysplasia, Neurodevelopmental Impairment
NCT06925360 · Bronchopulmonary Dysplasia
NCT07161908 · BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension
NCT06110481 · Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, and more
China Medical University Hospital
Taichung
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions